Table 1 Summary of demographic characteristics and baseline characteristics (ITT population)
From: Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Demographic | Placebo | VI 6.25 μg | VI 12.5 μg | VI 25 μg | Total |
|---|---|---|---|---|---|
N = 115 | N = 114 | N = 113 | N = 114 | N = 456 | |
Sex, n (%) | |||||
Female | 50 (43) | 43 (38) | 42 (37) | 45 (39) | 180 (39) |
Male | 65 (57) | 71 (62) | 71 (63) | 69 (61) | 276 (61) |
Age, years | |||||
Mean (SD) | 8.0 (1.81) | 8.0 (1.95) | 7.9 (1.74) | 7.9 (1.72) | 7.9 (1.80) |
Age group, n (%) | |||||
5–7 years | 51 (44) | 48 (42) | 42 (37) | 46 (40) | 187 (41) |
8–11 years | 64 (56) | 66 (58) | 71 (63) | 68 (60) | 269 (59) |
Race, n (%) | |||||
White | 68 (59) | 63 (55) | 55 (49) | 62 (54) | 248 (54) |
White and American Indian or Alaska Native | 20 (17) | 19 (17) | 26 (23) | 24 (21) | 89 (20) |
American Indian or Alaska Native | 16 (14) | 21 (18) | 17 (15) | 18 (16) | 72 (16) |
Asian | 6 (5) | 6 (5) | 7 (6) | 6 (5) | 25 (5) |
African American/African heritage | 5 (4) | 5 (4) | 5 (4) | 3 (3) | 18 (4) |
White and African American/African heritage | 0 | 0 | 2 (2) | 0 | 2 (<1) |
African American/African heritage and American Indian or Alaska Native | 0 | 0 | 1 (<1) | 0 | 1 (<1) |
African American/African heritage and Asian | 0 | 0 | 0 | 1 (<1) | 1 (<1) |
Ethnicity, n (%) | |||||
Hispanic/Latino | 81 (70) | 82 (72) | 82 (73) | 82 (72) | 327 (72) |
Not Hispanic/Latino | 34 (30) | 32 (28) | 31 (27) | 32 (28) | 129 (28) |
Baseline patient-reported outcomes | |||||
Rescue-free 24-h periods (SD), % | 18.8 (34.20) | 20.3 (35.65) | 19.1 (33.73) | 17.9 (33.60) | - |
Symptom-free 24-h periods (SD), % | 10.5 (22.50) | 7.9 (19.98) | 10.2 (22.35) | 6.7 (19.30) | - |
cACT score ≥20, n (%) | 58 (50) | 49 (43) | 48 (42) | 46 (40) | - |